Wednesday, Fresenius Medical Care AG & Co. KGaA (FMS) reported a rise in its second quarter earnings beating analysts' estimates, reflecting good performances in all its business segments and regions. The company also confirmed earnings and revenue guidance for the fiscal year.
The dialysis products and service provider's net income rose by 18% to $211 million or $0.71 per share for the second quarter from $179 million or $0.60 per share prior year. The operating income also rose significantly due to continued strong performance of renal products including PhosLo.
Four analysts polled by First Call/Thomson Financial expected the company to report earnings of $0.66 a share for the second quarter.
The German-based company's total net revenue rose by 11% to $2.66 billion for the second quarter from $2.40 billion prior year. Organic revenue growth worldwide was 7%; Dialysis Services revenue grew by 7% to $1,924 million. Analysts expected the company to report revenue of $2.57 billion for the second quarter.
The company's research and development expense increased to $20.65 million for the second quarter from $14.56 million prior year.
For the first half, the company's net income was $397 million or $1.34 per share compared with $339 million $1.15 per share prior year. The total net revenue rose by 10% to $5.17 billion from $4.72 billion prior year.
The Company confirmed the fiscal year net-income outlook in the range of $805 million to $825 million. The Company also reaffirmed its revenue guidance of $10.49 billion. Analysts expect the company to report revenue of $10.46 billion for the fiscal year.
The company also expects to spend $650 to $750 million on capital expenditures and $150 to $250 million on acquisitions. The debt/EBITDA ratio is projected to decrease to below 2.8 by the end of 2008.
For 2010, Fresenius Medical Care expects revenue of more than $11.5 billion. Earnings after tax are projected to grow in the low- to mid-teens each year.
Tuesday, the stock closed at $55.83 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.